Search research articles
Contact Us
Filters
Showing results (61-70 of 66) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 66 results.
Lupus
|
February 10, 2011
Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (II): thrombocytopenia and skin manifestations
R Cervera, M G Tektonidou, G Espinosa, et al.
Lupus
|
February 10, 2011
Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions
R Cervera, M G Tektonidou, G Espinosa, et al.
Lupus
|
February 10, 2011
Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies
G Ruiz-Irastorza, M J Cuadrado, I Ruiz-Arruza, et al.
Lupus
|
August 3, 2017
Hydroxychloroquine in the primary thrombosis prophylaxis of antiphospholipid antibody positive patients without systemic autoimmune disease
D Erkan, O Unlu, S Sciascia, et al.
Journal of Thrombosis and Haemostasis : JTH
|
July 7, 2018
McMaster RARE-Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome
K Legault, H Schunemann, C Hillis, et al.
BJOG : an International Journal of Obstetrics and Gynaecology
|
September 18, 2018
Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study
G R de Jesús, S Sciascia, D Andrade, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 66) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 66 results.
Lupus
|
February 10, 2011
Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (II): thrombocytopenia and skin manifestations
R Cervera, M G Tektonidou, G Espinosa, et al.
Lupus
|
February 10, 2011
Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions
R Cervera, M G Tektonidou, G Espinosa, et al.
Lupus
|
February 10, 2011
Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies
G Ruiz-Irastorza, M J Cuadrado, I Ruiz-Arruza, et al.
Lupus
|
August 3, 2017
Hydroxychloroquine in the primary thrombosis prophylaxis of antiphospholipid antibody positive patients without systemic autoimmune disease
D Erkan, O Unlu, S Sciascia, et al.
Journal of Thrombosis and Haemostasis : JTH
|
July 7, 2018
McMaster RARE-Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome
K Legault, H Schunemann, C Hillis, et al.
BJOG : an International Journal of Obstetrics and Gynaecology
|
September 18, 2018
Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study
G R de Jesús, S Sciascia, D Andrade, et al.
Page
of 7